Funding gap for immunization across 94 low- and middle-income countries

Sachiko Ozawa, Simrun Grewal, Allison Portnoy, Anushua Sinha, Richard Arilotta, Meghan L. Stack, Logan Brenzel

Research output: Contribution to journalArticle

Abstract

Novel vaccine development and production has given rise to a growing number of vaccines that can prevent disease and save lives. In order to realize these health benefits, it is essential to ensure adequate immunization financing to enable equitable access to vaccines for people in all communities. This analysis estimates the full immunization program costs, projected available financing, and resulting funding gap for 94 low- and middle-income countries over five years (2016–2020). Vaccine program financing by country governments, Gavi, and other development partners was forecasted for vaccine, supply chain, and service delivery, based on an analysis of comprehensive multi-year plans together with a series of scenario and sensitivity analyses. Findings indicate that delivery of full vaccination programs across 94 countries would result in a total funding gap of $7.6 billion (95% uncertainty range: $4.6–$11.8 billion) over 2016–2020, with the bulk (98%) of the resources required for routine immunization programs. More than half (65%) of the resources to meet this funding gap are required for service delivery at $5.0 billion ($2.7–$8.4 billion) with an additional $1.1 billion ($0.9–$2.7 billion) needed for vaccines and $1.5 billion ($1.1–$2.0 billion) for supply chain. When viewed as a percentage of total projected costs, the funding gap represents 66% of projected supply chain costs, 30% of service delivery costs, and 9% of vaccine costs. On average, this funding gap corresponds to 0.2% of general government expenditures and 2.3% of government health expenditures. These results suggest greater need for country and donor resource mobilization and funding allocation for immunizations. Both service delivery and supply chain are important areas for further resource mobilization. Further research on the impact of advances in service delivery technology and reductions in vaccine prices beyond this decade would be important for efficient investment decisions for immunization.

Original languageEnglish (US)
Pages (from-to)6408-6416
Number of pages9
JournalVaccine
Volume34
Issue number50
DOIs
StatePublished - Dec 7 2016
Externally publishedYes

Fingerprint

funding
Immunization
immunization
income
Vaccines
vaccines
supply chain
Costs and Cost Analysis
Immunization Programs
Health Expenditures
Government Financing
health care costs
Insurance Benefits
vaccine development
Uncertainty
Vaccination
uncertainty
Technology
vaccination
Research

Keywords

  • Financing
  • Funding gap
  • Immunization
  • Low- and middle-income country
  • Vaccine

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Ozawa, S., Grewal, S., Portnoy, A., Sinha, A., Arilotta, R., Stack, M. L., & Brenzel, L. (2016). Funding gap for immunization across 94 low- and middle-income countries. Vaccine, 34(50), 6408-6416. https://doi.org/10.1016/j.vaccine.2016.09.036

Funding gap for immunization across 94 low- and middle-income countries. / Ozawa, Sachiko; Grewal, Simrun; Portnoy, Allison; Sinha, Anushua; Arilotta, Richard; Stack, Meghan L.; Brenzel, Logan.

In: Vaccine, Vol. 34, No. 50, 07.12.2016, p. 6408-6416.

Research output: Contribution to journalArticle

Ozawa, S, Grewal, S, Portnoy, A, Sinha, A, Arilotta, R, Stack, ML & Brenzel, L 2016, 'Funding gap for immunization across 94 low- and middle-income countries', Vaccine, vol. 34, no. 50, pp. 6408-6416. https://doi.org/10.1016/j.vaccine.2016.09.036
Ozawa S, Grewal S, Portnoy A, Sinha A, Arilotta R, Stack ML et al. Funding gap for immunization across 94 low- and middle-income countries. Vaccine. 2016 Dec 7;34(50):6408-6416. https://doi.org/10.1016/j.vaccine.2016.09.036
Ozawa, Sachiko ; Grewal, Simrun ; Portnoy, Allison ; Sinha, Anushua ; Arilotta, Richard ; Stack, Meghan L. ; Brenzel, Logan. / Funding gap for immunization across 94 low- and middle-income countries. In: Vaccine. 2016 ; Vol. 34, No. 50. pp. 6408-6416.
@article{1a5fcb6a396543508336b59f0cc1a9bf,
title = "Funding gap for immunization across 94 low- and middle-income countries",
abstract = "Novel vaccine development and production has given rise to a growing number of vaccines that can prevent disease and save lives. In order to realize these health benefits, it is essential to ensure adequate immunization financing to enable equitable access to vaccines for people in all communities. This analysis estimates the full immunization program costs, projected available financing, and resulting funding gap for 94 low- and middle-income countries over five years (2016–2020). Vaccine program financing by country governments, Gavi, and other development partners was forecasted for vaccine, supply chain, and service delivery, based on an analysis of comprehensive multi-year plans together with a series of scenario and sensitivity analyses. Findings indicate that delivery of full vaccination programs across 94 countries would result in a total funding gap of $7.6 billion (95{\%} uncertainty range: $4.6–$11.8 billion) over 2016–2020, with the bulk (98{\%}) of the resources required for routine immunization programs. More than half (65{\%}) of the resources to meet this funding gap are required for service delivery at $5.0 billion ($2.7–$8.4 billion) with an additional $1.1 billion ($0.9–$2.7 billion) needed for vaccines and $1.5 billion ($1.1–$2.0 billion) for supply chain. When viewed as a percentage of total projected costs, the funding gap represents 66{\%} of projected supply chain costs, 30{\%} of service delivery costs, and 9{\%} of vaccine costs. On average, this funding gap corresponds to 0.2{\%} of general government expenditures and 2.3{\%} of government health expenditures. These results suggest greater need for country and donor resource mobilization and funding allocation for immunizations. Both service delivery and supply chain are important areas for further resource mobilization. Further research on the impact of advances in service delivery technology and reductions in vaccine prices beyond this decade would be important for efficient investment decisions for immunization.",
keywords = "Financing, Funding gap, Immunization, Low- and middle-income country, Vaccine",
author = "Sachiko Ozawa and Simrun Grewal and Allison Portnoy and Anushua Sinha and Richard Arilotta and Stack, {Meghan L.} and Logan Brenzel",
year = "2016",
month = "12",
day = "7",
doi = "10.1016/j.vaccine.2016.09.036",
language = "English (US)",
volume = "34",
pages = "6408--6416",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "50",

}

TY - JOUR

T1 - Funding gap for immunization across 94 low- and middle-income countries

AU - Ozawa, Sachiko

AU - Grewal, Simrun

AU - Portnoy, Allison

AU - Sinha, Anushua

AU - Arilotta, Richard

AU - Stack, Meghan L.

AU - Brenzel, Logan

PY - 2016/12/7

Y1 - 2016/12/7

N2 - Novel vaccine development and production has given rise to a growing number of vaccines that can prevent disease and save lives. In order to realize these health benefits, it is essential to ensure adequate immunization financing to enable equitable access to vaccines for people in all communities. This analysis estimates the full immunization program costs, projected available financing, and resulting funding gap for 94 low- and middle-income countries over five years (2016–2020). Vaccine program financing by country governments, Gavi, and other development partners was forecasted for vaccine, supply chain, and service delivery, based on an analysis of comprehensive multi-year plans together with a series of scenario and sensitivity analyses. Findings indicate that delivery of full vaccination programs across 94 countries would result in a total funding gap of $7.6 billion (95% uncertainty range: $4.6–$11.8 billion) over 2016–2020, with the bulk (98%) of the resources required for routine immunization programs. More than half (65%) of the resources to meet this funding gap are required for service delivery at $5.0 billion ($2.7–$8.4 billion) with an additional $1.1 billion ($0.9–$2.7 billion) needed for vaccines and $1.5 billion ($1.1–$2.0 billion) for supply chain. When viewed as a percentage of total projected costs, the funding gap represents 66% of projected supply chain costs, 30% of service delivery costs, and 9% of vaccine costs. On average, this funding gap corresponds to 0.2% of general government expenditures and 2.3% of government health expenditures. These results suggest greater need for country and donor resource mobilization and funding allocation for immunizations. Both service delivery and supply chain are important areas for further resource mobilization. Further research on the impact of advances in service delivery technology and reductions in vaccine prices beyond this decade would be important for efficient investment decisions for immunization.

AB - Novel vaccine development and production has given rise to a growing number of vaccines that can prevent disease and save lives. In order to realize these health benefits, it is essential to ensure adequate immunization financing to enable equitable access to vaccines for people in all communities. This analysis estimates the full immunization program costs, projected available financing, and resulting funding gap for 94 low- and middle-income countries over five years (2016–2020). Vaccine program financing by country governments, Gavi, and other development partners was forecasted for vaccine, supply chain, and service delivery, based on an analysis of comprehensive multi-year plans together with a series of scenario and sensitivity analyses. Findings indicate that delivery of full vaccination programs across 94 countries would result in a total funding gap of $7.6 billion (95% uncertainty range: $4.6–$11.8 billion) over 2016–2020, with the bulk (98%) of the resources required for routine immunization programs. More than half (65%) of the resources to meet this funding gap are required for service delivery at $5.0 billion ($2.7–$8.4 billion) with an additional $1.1 billion ($0.9–$2.7 billion) needed for vaccines and $1.5 billion ($1.1–$2.0 billion) for supply chain. When viewed as a percentage of total projected costs, the funding gap represents 66% of projected supply chain costs, 30% of service delivery costs, and 9% of vaccine costs. On average, this funding gap corresponds to 0.2% of general government expenditures and 2.3% of government health expenditures. These results suggest greater need for country and donor resource mobilization and funding allocation for immunizations. Both service delivery and supply chain are important areas for further resource mobilization. Further research on the impact of advances in service delivery technology and reductions in vaccine prices beyond this decade would be important for efficient investment decisions for immunization.

KW - Financing

KW - Funding gap

KW - Immunization

KW - Low- and middle-income country

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=84998579534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84998579534&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2016.09.036

DO - 10.1016/j.vaccine.2016.09.036

M3 - Article

AN - SCOPUS:84998579534

VL - 34

SP - 6408

EP - 6416

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 50

ER -